key: cord-0963150-h2slfavm
authors: Patil, S. A.; Vail, D. G.; Cox, J. T.; Chen, E. M.; Mruthyunjaya, P.; Tsai, J. C.; Parikh, R.
title: Private Equity Acquisition in Ophthalmology and Optometry: A Time Series Analysis of the Pre-COVID, COVID Pre-Vaccine, and COVID Post-Vaccine Eras
date: 2022-02-03
journal: nan
DOI: 10.1101/2022.02.03.22270390
sha: c70ddfd75cbd2754d4ccf4c13f5593da7e26d724
doc_id: 963150
cord_uid: h2slfavm

Objective: To identify temporal and geographic trends in private equity (PE) backed acquisitions of ophthalmology and optometry practices in the United States from 2012 to 2021. Design: Cross-sectional time series analysis using acquisition data from 10/21/2019 to 9/1/2021 compared to previously published data from 1/1/2012-10/20/2019. Acquisition data was compiled from 6 financial databases, 5 industry news outlets, and publicly available press releases. Linear regression models were used to compare rates of acquisition. Subjects: 245 PE acquisitions of ophthalmology and optometry practices in the United States between 10/21/2019 and 9/1/2021. Measures: Number of total acquisitions, practice type, locations, provider details, and geographic footprint. Results: 245 practices associated with 614 clinical locations and 948 ophthalmologists or optometrists were acquired by 30 PE-backed platform companies. 18 of 30 platform companies were new compared to our prior study. Of these acquisitions from 10/21/2019 - 9/1/2021, 127, 29, and 89 were comprehensive, retina, and optometry practices, respectively. From 2012 to 2021, monthly acquisitions increased by 0.947 acquisitions per year (p<0.001*). Texas, Florida, Michigan, and New Jersey were the states with the greatest number of PE acquisitions with 55, 48, 29, 28 clinic acquisitions, respectively. Average monthly PE acquisitions were 5.71 per month from 1/1/2019 - 2/29/2020 (pre-COVID), 5.30 per month 3/1/2020-12/31/2020 (COVID pre-vaccine, p=0.8072), and were 8.78/month 1/1/2021-9/1/2021 (COVID post-vaccine, p=0.1971). Conclusion: PE acquisitions increased from 2012-2021 as companies continue to utilize both regionally focused and multi-state models of add-on acquisitions.

Private equity (PE) investment is a major driving force in healthcare today, offering 106 consolidation and the ability to scale up independent practices to compete in a dynamic market. 107

For example, one recent study found that in Maryland and New Jersey, more than 25% of 108 urologists were employed by a private equity backed platform company [1] . However, recent 109 trend of private equity (PE) backed consolidation in ophthalmology and the healthcare system as 110 a whole continues to raise concerns regarding patient care, physician autonomy, and overall 111 health system costs [2, 3] . In the typical PE model, firms invest into an ophthalmic management 112 group, or platform company, which provides streamlined operational efficiency, revenue 113 enhancement, and increased market share [4] . Subsequently, there is an anticipated return on 114 investment within three to six years through recapitalization. PE continues to affect practices in 115 many subspecialities including radiology, dermatology, gastroenterology, and others as they 116 continue to expand their presence [2, 5, 6] . 117 We have previously reported on the rapid increase in private equity investments within 118 the field of ophthalmology and optometry from 2012 through much of 2019 as well as the 119 recapitalization of some of those platform companies [7] . Ophthalmology remains lucrative for 120 the private investment model for several reasons. Firstly, there is a very defined referral path 121 through which the business of the ophthalmologist is clearly defined [8] . Further, high procedure 122 volume with numerous patients, unique pay structures, and an aging population with heavy 123 demand for ophthalmic care creates an ideal market for business growth. Even further, 124 ophthalmologic clinics may potentially have lucrative cash-pay procedures (e.g., cosmetic 125 injections or premium intraocular lenses) [9] . Private equity (PE) investment provides an 126 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 3, 2022. ; https://doi.org/10.1101/2022.02.03.22270390 doi: medRxiv preprint attractive alternative to hospital-physician alignment, and many specialties have seen a recent 127 rise in PE-driven establishment of consolidated platform companies.  128   COVID-19 has had a dramatic impact on healthcare operations in the outpatient setting  129 with some studies noting ophthalmology had the highest drop in outpatient volume [10] .To 130 prepare for the influx of infected persons, health care facilities largely rescheduled elective or 131 less urgent health care procedures [11] . Given reduced revenue in the setting of the pandemic, 132 there have been furloughs, salary reductions, and loss of benefits for health care workers [12] . On 133 one hand, this loss of revenue may make PE acquisitions slow as the return on investment (ROI) 134 could potentially be less than previously expected. However, the financial pressure on physicians 135 and clinics may also lead to easier acquisition of newly distressed assets. Further, the economic 136 policy of low interest rates since the pandemic began would allow highly capitalized PE firms to 137 more easily obtain financing and expand their footprint [13] . Researchers have speculated that 138 private equity investment model, which mitigates physicians' personal risk, would be an enticing 139 prospect for healthcare institutions wishing to protect themselves from economic downfall [14] . 140

Anecdotally, physicians in practice have noted a desire to use PE as a lucrative exit from the 141 burdensome tasks of administering their own practices and focusing solely on patient care but 142 employees with limited to no operational control [8] . 143 Therefore, the objective of this study was to assess rates and geographic trends of PE 144 acquisitions of ophthalmology and optometry practices in the United States over the last decade. 145 146 147 148 149 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 3, 2022. until January 2021 [16] . 164

Methods for identification and inclusion of private equity backed acquisitions have been 165 described elsewhere [7] . In summary, after the initial investment of creation of a platform 166 company or acquisition of a platform practice group, the platform company will acquire 167 additional practices. We sought to identify and characterize these acquisitions as well as the acquisition, we used information from press releases and web archives dated closest to the 183 transaction closure date. Of note, for certain acquisitions, if we were unable to specify the exact 184 locations of acquired practices, they were not included in the geographic map or used to calculate 185 totals by state. However, we did include these details in the number of total practices. 186

We identified the platform company, investing PE firm, and date of initial PE investment 187 for each platform. For platform company formations associated with multiple acquired practices, 188 each practice was counted as a separate acquisition. In cases where the transaction closure date 189 was unavailable, the date of the earliest report of the acquisition was used as a surrogate. If the 190 explicit formation of a platform company was not evident, we defined the first investment of a 191 PE firm in an eye care practice or previous eye care management group as the formation of a 192 platform. We also stratified each acquisition into 3 primary practice specialties: comprehensive, 193 optometry, or retina, depending on many services provided within the practice. Descriptive data 194 of platform companies were reported with means, medians, ranges, and standard deviations. 195 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 3, 2022. 

Mean number of acquisitions per month were compared using two-tailed unpaired t-tests. 210

We specified a linear regression model of time series data with robust standard errors including 211 data from the previously published study, from January 1 st , 2012 to September 1 st , 2021. We 212 created a graph of acquisitions for the entire data set after calculating a three-month average 213 number of clinics acquired. Three months was chosen to control for variance in month-to-month 214 data. P values of <0.05 were considered statistically significant. 215 216

Description of Acquisitions 218 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. As has been seen in other fields of medicine, private equity acquisitions continue to 263 increase, with certain platform companies serving as hubs in geographic areas (i.e., Midwest 264 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 3, 2022. ; https://doi.org/10.1101/2022.02.03.22270390 doi: medRxiv preprint Vision Partners, EyeSouth Partners). Particularly, given the nature of ophthalmology as a field of 265 many independent practitioners, we anticipate consistent with previous literature, the PE model 266 specifically targets high value "platform practices," and then works to acquire add-on practices 267

to scale them up [21] . Consistent with this trend, we found that practices with a median of 3 268 ophthalmologists were acquired by PE in this time frame. 269

The ever-increasing presence of private equity in healthcare remains an ethically 270 ambiguous question which will require rigorous discussion and research to fully understand the 271 effects on patients, physicians, and the economy at large. On one hand, consolidation of 272 independent practices in ophthalmology, which is largely consistent of small, independent 273 practices, will allow groups to be represented by economically savvy and robust financial 274 groups. Private equity firms utilize capital from investors with the goal to return a profit by 275 adding value or decreasing overhead. This can be done through tactics aimed at consolidation 276 and efficiency such as outsourcing billing, layoffs, and increasing prices and patient volume [22] . Various elements interplay to make the environment ripe for private equity consolidation. 281

Physicians may be drawn to large buyouts from private equity in the form of large upfront 282 payments from sales of their practice. The large payouts may be taxed at capital gains rates 283 rather than income tax rates, making them particularly appealing [22] . Declining reimbursements 284 for ophthalmologists may also make the large payouts from private equity firms appealing. 285

Additionally, the demand for ophthalmology remains high, and it is predicted to be the surgical 286 subspeciality with the greatest predicted workforce shortage by 2025 [24] . Physicians may opt to 287 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 3, 2022. would appear attractive to practices with less financial leverage [27] . 306

Despite research indicating that hospitals acquired by private equity were associated with 307 larger increases in net income and charges, the results remain heterogenous as far as patient 308 outcomes [28] . A recent report of private equity investment in nursing homes was associated with 309 increased ambulatory care-sensitive condition emergency department visit, increased 310 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 3, 2022. hospitalizations, and higher Medicare costs [29] . Further, academic institutions will face new 311 challenges in the setting of private equity expansion, as there will be increased financial strain on 312 centers which traditionally rely on non-aligned general practitioners for subspecialty referrals. 313

This financial strain may have deleterious consequences in terms of the capacity for these 314 academic centers to conduct much of the basic and translational research needed to push the field 315 forward, and to adequately train future residents. 316 Future ophthalmologists will have to brace for the fact that there will be no mechanism to 317 control their practice, and financial compensation will likely be less with a future revenue stream 318 discounted [30] . Anecdotally, several physicians have written that granular encroachment is not 319 something they have experienced at the practice management level, however, acquisitions are 320 relatively recent and a conflict of interest may be present as many physicians may not be 321 comfortable publicly speaking negatively about their employer [31] . 322

Further concerns regarding PE companies creating local monopolies may also affect both 323 patient and physician choice when seeking care, employment, or referral centers. Previous work 324 outlines a trend of platform companies creating geographic strongholds in certain parts of the 325 United States, which continues to be a trend in this new data [7] . It has been documented that a 326 sizeable number of patients will chose to go to a local hospital independent of decreased 327 mortality risk, higher survival benefit, or revision risk compared to a regional hospital. Other 328 studies have shown that patients do not wish to travel more than 4 hours to obtain the care they 329 need [32-34]. Given that patients will not typically travel large distances for care, it is important 330 to consider that these private equity firms are creating localized monopolies such that patients are 331 limited in the type and location of care they receive. Concerns over private equity creating 332 miniature monopolies has led to calls for anti-trust policymakers from the Federal Trade 333 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 3, 2022. There are limitations to this study. Two acquisitions were very large and impossible to 338 add to our geographic depiction of acquisitions. This was Keplr Visions acquisition of 43 339 optometry practices and AEG visions' acquisition of 50 comprehensive or multi-specialty 340 practices. We anticipate that these large, multi-practice acquisitions would further support our 341 finding that private equity acquisitions are growing with add-on practices in certain geographic 342 strongholds. Further, for some practices, if information was not available on the nature of the 343 practice or staff through web archives at the time of acquisition, thus we opted to utilize 344 information from the date closest to the acquisition. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 3, 2022. ; https://doi.org/10.1101/2022.02.03.22270390 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 3, 2022. ; https://doi.org/10.1101/2022.02.03.22270390 doi: medRxiv preprint

Urology Practice Acquisitions by Private Equity Firms from

Physician Practice Management and Private 361 Equity: Market Forces Drive Change

Private equity investment in health care 364 services

Trends in Private Equity Acquisition 367 of Dermatology Practices in the United States

White Paper: Corporatization in Radiology

Gastroenterology Physician Practice 373 Management and Private Equity: Thriving in Uncertain Times

Private Equity in Ophthalmology and Optometry: Analysis of Acquisitions from 2012 378 through 2019 in the United States

Private equity ensures strong succession, peace of mind for some practices

The Emergence of Private Equity in 385

COVID-19 and Use of Teleophthalmology

Telehealth Outpatient Visits During the COVID-19 Pandemic

The financial and employment effects of coronavirus disease 394 2019 on physicians in the United States

How Low Interest Rates Can Hurt Competition, and the Economy

Private Equity-Backed Hospital Investments and the Impact of 401 the Coronavirus Disease 2019 (COVID-19) Epidemic," (in eng)

WHO Declares COVID-19 a Pandemic

Equitable allocation of COVID-19 vaccines in the United States

Equity Investment In Health Care: Perspectives From Ophthalmology

Potential Implications of Private Equity Investments in Health 417 Care Delivery

Private Equity and Urology: An Emerging Model for 420 Independent Practice

National and Regional Projections of Supply and Demand for Surgical 424 Specialty Practitioners: e2013-2025 425

Recommendations for urgent and nonurgent patient care

Impact of COVID-19 on 431 Ophthalmology and Future Practice of Medicine

Transition Back to Patient Care

Associated With Private Equity Acquisition

Private Equity In 440 Dermatology: Effect On Price, Utilization, And Spending

Corporatization in Ophthalmology

Is a Private Equity Deal Right for You?

Parental 448 preference regarding hospitals for children undergoing surgery: a trade-off between travel 449 distance and potential outcome improvement

Determination of patient preference for location of elective 452 abdominal aortic aneurysm surgery

Patient 455 preferences for location of care: implications for regionalization

Congress Renews Push on Investigating Private Equity Investment in Healthcare